June 01, 2022Fera Pharmaceuticals is launching Phospholine Iodide® June 1st!
April 11, 2022Fera Pharmaceuticals Announces FDA Orphan Designation for Phospholine Iodide® for the Treatment of Stargardt Disease
March 02, 2022Fera Obtains Orphan Drug Designation for Naproxcinod for the Treatment of Sickle Cell Disease
February 09, 2022Fera announces it has executed an agreement for the long-term manufacturing of Phospholine Iodide®️
August 04, 2021Fera Pharmaceuticals is pleased to announce that it has completed an agreement with Pfizer to acquire Phospholine Iodide®
August 07, 2020Fera Announces the Launch of Dexamethasone 4 mg Tablets in Unit Dose Packaging
April 01, 2019Fera Pharmaceuticals Announces FDA Approval of AvaclyrTM (acyclovir ophthalmic ointment)